Millennium Management’s CAMP4 Therapeutics CAMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$114K Sell
28,336
-15,567
-35% -$63.9K ﹤0.01% 5738
2026
Q2
$192K Sell
43,903
-42,015
-49% -$181K ﹤0.01% 5335
2026
Q1
$379K Buy
85,918
+75,816
+751% +$360K ﹤0.01% 4907
2025
Q4
$61.9K Sell
10,102
-84,969
-89% -$361K ﹤0.01% 5709
2025
Q3
$285K Sell
95,071
-37,965
-29% -$70.3K ﹤0.01% 5360
2025
Q2
$193K Buy
+133,036
New +$265K ﹤0.01% 5378

Other funds holding CAMP

Millennium Management's CAMP Position: Q3 2026 in Review

Millennium Management reduced its CAMP4 Therapeutics (CAMP) stake by 35% in Q3 2026, selling an estimated $63.9K and leaving 28,336 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #5738.

Millennium Management first reported a position in CAMP in Q2 2025 and has held it in 6 quarters since. The position peaked at $379K in Q1 2026. 69 funds tracked by Wall St. Rank hold CAMP as of Q3 2026.

  • Millennium Management held 28,336 shares of CAMP4 Therapeutics worth $114K as of Q3 2026.
  • Millennium Management sold 15,567 CAMP4 Therapeutics shares in Q3 2026, an estimated $63.9K.
  • CAMP4 Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #5738 holding.
  • Millennium Management first reported a position in CAMP4 Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • Millennium Management's CAMP4 Therapeutics position peaked at $379K in Q1 2026.
  • 69 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.